GATX (NYSE:GATX) 주식

GATX

GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.

Tesla's Sky-High Surge

Equities

News

Previews

Tech

Trading Ideas

ABBV

AGYS

ASML

BJRI

CHKP

CHTR

CMCSA

DECK

GOOG

GOOGL

JNPR

NFLX

NXPI

ODFL

ORLY

SKYW

SPOT

TSLA

VRSN

S&amp;P 500 기업들 중 약 14%가 6월 분기 실적을 발표했으며, 더 넓은 지수를 구성하는 기업들의 혼합 실적 성장률은 여전히 ​​양호하다. 이번 주에는 기술 보고 시즌이 공식적으로 시작될 것이며, 이는 최근 주에 가파른 하락세를 보인 시장의 향방을 잠재적으로 결정할 수 있다.

테슬라, 알파벳, GM 및 포드가 이번 주 실적 발표 주도하며 상승세 유지 위해 고군분투

GATX Corp

WIIM

MASI

Masimo shares are trading lower. The company reported Q1 financial results and announced the sale of its consumer audio business for $350 million.

Astronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRO#NASDAQ">ATRO</a>) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.28 by 57.14 percent. This is a 588.89 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $205.94 million which beat the analyst consensus estimate of $192.53 million by 6.97 percent. This is a 11.27 percent increase over sales of $185.07 million the same period last year.

Earnings

Earnings Beats

ATRO

Astronics Q1 Adj. EPS $0.44 Beats $0.28 Estimate, Sales $205.94M Beat $192.53M Estimate

Prelude Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRLD#NASDAQ">PRLD</a>) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.47) by 10.64 percent. This is unchanged from the same period last year.

PRLD

Prelude Therapeutics Q1 EPS $(0.42) Beats $(0.47) Estimate

Douglas Emmett (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEI#NYSE">DEI</a>) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.39 by 2.56 percent. This is a 11.11 percent decrease over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $251.53 million which beat the analyst consensus estimate of $246.46 million by 2.06 percent. This is a 2.68 percent increase over sales of $244.97 million the same period last year.

Douglas Emmett Q1 FFO $0.40 Beats $0.39 Estimate, Sales $251.53M Beat $246.46M Estimate

Energy markets are caught in a whirlwind of uncertainty. Tariffs, shifting tanker routes, and geopolitical risks have made volatility the only constant. Traditional forecasts, which banked on low energy prices this year, are now shaky at best. A sudden potential maritime conflict, burning through vast amounts of fuel, could easily upend these projections, leaving investors scrambling to adapt.
<h2 class="wp-block-heading">Renewables Outshine Traditional Oil</h2>
Investment dollars are increasingly flowing into renewable energy as global economies double down on carbon neutrality goals. With an oversupply looming, new oil projects are quietly fading. While exploration and drilling costs have dipped, the financial strain of keeping the oil sector competitive-coupled with tighter environmental rules-keeps climbing. Even U.S. shale, once a beacon of energy independence, struggles to match renewables on cost. Capital isn't wavering anymore; green energy offers better returns. Oil's heavy legacy costs and regulatory hurdles are testing investor patience to its limits. Adding to oil's woes, a potential U.S.-Iran nuclear deal could flood the market with an extra two million barrels per day. If that happens, Brent prices might slide toward $50, forcing OPEC+ and U.S. producers to slash output-a looming risk for the entire industry.
<h2 class="wp-block-heading">Europe's Quest for Energy Independence</h2>
European nations are pushing hard to diversify their energy imports. The EU's import landscape has shifted dramatically in recent years. In 2024, the U.S. emerged as the bloc's top supplier of liquefied natural gas (LNG) and distillates, while Norway solidified its role as the leading provider of pipeline gas, according to Eurostat data. This pivot away from historical suppliers has slashed fossil fuel imports from certain regions by over 80% by late 2023. Yet, this newfound independence comes at a steep price. After price caps were lifted, EU energy bills surged 12% on average, with January 2023 alone seeing a 16% spike. For European consumers, inflation has become the steep cost of energy security.
<h2 class="wp-block-heading">OPEC+ Faces a Balancing Act</h2>
OPEC+ finds itself in a tight spot. The oil cartel aims to hold its ground in the global market and avoid a sharp, lasting drop in prices, all while maintaining ties with major buyers like India, Europe, and China-each with their own agendas. Starting April 2025, OPEC+ plans to boost production by 411,000 barrels per day, a move driven by the need to secure market share amid trade frictions. The group isn't as worried about price dips as it is about losing ground to the U.S., where shale production remains a persistent challenge.
This ramp-up has already rattled markets. Crude prices fell below $69, the lowest since March 11, following the Trump administration's <a href="https://www.whitehouse.gov/presidential-actions/2025/03/imposing-tariffs-on-countries-importing-venezuelan-oil/">sanctions on Venezuelan oil</a> in March. Those sanctions forced companies like Global Oil to pull out, with Chevron having exited earlier, leaving Venezuela increasingly isolated. This disruption threatens supply chains and raises doubts about the country's oil industry survival. 
<h2 class="wp-block-heading">Looking Ahead to Energy Markets</h2>
The global energy landscape is shifting in real time. Supply chains are rerouting, partnerships are fraying, and climate goals are bending under pressure. One thing is clear: the era of predictable, cheap energy is gone. Investors, who see volatility as a blip, risks to be left behind. Going through the points in thesis and briefly, let&#8217;s note the following: -Price Swings Intensify: Geopolitical tensions will keep oil and gas prices on a rollercoaster. -Trade Routes Evolve: Traditional energy flows face ongoing disruptions as Europe seeks new import sources. -Green Energy Gains Ground: Despite the new U.S. administration's stance, investments in renewables surge globally. -Resource Rivalries Heat Up: Major economies will compete fiercely for reliable energy supplies. -Strategic Reserves in Play: Governments may tap oil and gas reserves to counter price spikes from trade disputes. Energy markets in 2025 are a test of resilience. Investors should actively adapt if they don&#8217;t want to fall by the wayside.

Commodities

Global

Opinion

Markets

Renewables Outpace Oil In Attracting Investments

UPST

Upstart Holdings shares are trading lower after the company issued Q2 sales guidance below estimates.

Ardent Health Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARDT#NYSE">ARDT</a>) affirms FY2025 GAAP EPS guidance from $1.73-$2.01 to $1.73-$2.01 vs $1.90 analyst estimate. Affirms FY2025 sales outlook from $6.20 billion-$6.45 billion to $6.20 billion-$6.45 billion vs $6.33 billion estimate.

Guidance

ARDT

Ardent Health Partners Affirms FY2025 GAAP EPS Guidance of $1.73-$2.01 vs $1.90 Est; Affirms FY2025 Sales Guidance of $6.20B-$6.45B vs $6.33B Est

Forrester Res (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORR#NASDAQ">FORR</a>) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.08 by 37.5 percent. This is a 21.43 percent decrease over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $89.88 million which missed the analyst consensus estimate of $90.70 million by 0.90 percent. This is a 10.19 percent decrease over sales of $100.08 million the same period last year.

Earnings Misses

FORR

Forrester Res Q1 Adj. EPS $0.11 Beats $0.08 Estimate, Sales $89.88M Miss $90.70M Estimate

Vestis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.14 by 135.71 percent. This is a 138.46 percent decrease over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $665.25 million which missed the analyst consensus estimate of $690.03 million by 3.59 percent. This is a 5.69 percent decrease over sales of $705.37 million the same period last year.

VSTS

Vestis Q2 Adj. EPS $(0.05) Misses $0.14 Estimate, Sales $665.25M Miss $690.03M Estimate

SMCI

Super Micro Computer shares are trading lower after the company reported worse-than-expected Q3 financial results, issued Q4 guidance below estimates, and cut its FY25 sales guidance.

CRISPR Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>) reported quarterly losses of $(1.58) per share which missed the analyst consensus estimate of $(1.25) by 26.4 percent. This is a 10.49 percent decrease over losses of $(1.43) per share from the same period last year. The company reported quarterly sales of $865.00 thousand which missed the analyst consensus estimate of $6.39 million by 86.46 percent. This is a 71.63 percent increase over sales of $504.00 thousand the same period last year.

CRSP

CRISPR Therapeutics Q1 EPS $(1.58) Misses $(1.25) Estimate, Sales $865.00K Miss $6.39M Estimate

Viant Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.10) by 130 percent. This is a 50 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $70.64 million which beat the analyst consensus estimate of $67.39 million by 4.82 percent. This is a 32.31 percent increase over sales of $53.39 million the same period last year.

Viant Technology Q1 Adj. EPS $0.03 Beats $(0.10) Estimate, Sales $70.64M Beat $67.39M Estimate

SuRo Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSSS#NASDAQ">SSSS</a>) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 23.08 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $499.09 thousand which missed the analyst consensus estimate of $1.20 million by 58.41 percent. This is a 67.34 percent decrease over sales of $1.53 million the same period last year.

SSSS

SuRo Capital Q1 GAAP EPS $(0.16) Misses $(0.14) Estimate, Sales $499.09K Miss $1.20M Estimate

Chipotle Mexican Grill shares are trading higher after the company announced the appointment of a new COO.

NewtekOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEWT#NASDAQ">NEWT</a>) affirms FY2025 GAAP EPS guidance from $2.10-$2.50 to $2.10-$2.50 vs $2.21 analyst estimate..

NEWT

NewtekOne Affirms FY2025 GAAP EPS Guidance of $2.10-$2.50 vs $2.21 Est

DGNX

Shaikh Mohammed Bin Sultan Bin Hamdan Al Nahyan Acquires Warrants Of Diginex Limited To Purchase 6.75M Ordinary Shares Of Diginex For $300M Via Private Transaction

Ardent Health Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARDT#NYSE">ARDT</a>) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.20 by 45 percent. The company reported quarterly sales of $1.50 billion which met the analyst consensus estimate.

Ardent Health Partners Q1 EPS $0.29 Beats $0.20 Estimate, Sales $1.50B Inline

CRISPR Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>) reported quarterly losses of $(1.58) per share which missed the analyst consensus estimate of $(1.21) by 30.58 percent. This is a 10.49 percent decrease over losses of $(1.43) per share from the same period last year. The company reported quarterly sales of $865.00 thousand which missed the analyst consensus estimate of $6.50 million by 86.69 percent. This is a 71.63 percent increase over sales of $504.00 thousand the same period last year.

CRISPR Therapeutics Q1 EPS $(1.58) Misses $(1.21) Estimate, Sales $865.00K Miss $6.50M Estimate

Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) released its third-quarter results after Tuesday's closing bell. Here's a look at the details<a href="https://www.benzinga.com/pressreleases/25/05/b45235128/supermicro-announces-third-quarter-fiscal-year-2025-financial-results"> from the report. </a>
The Details: Super Micro Computer reported quarterly earnings of 31 cents per share, which missed the analyst consensus estimate of 50 cents by 38%. Quarterly revenue came in at $4.6 billion, which missed the analyst consensus estimate of $5.42 billion by 15.1%.
Non-GAAP gross margin was 9.7% with adjustments for stock-based compensation expenses of $7 million.&nbsp;
The company had <a href="https://www.benzinga.com/news/earnings/25/04/45086254/super-micro-computer-stock-is-tanking-after-hours-whats-fueling-the-sell-off">previously said </a>it expected to report third-quarter revenue of $4.5 billion to $4.6 billion, and adjusted earnings in the range of 29 cents to 31 cents per share. 
Read Next:&nbsp; <a href="https://www.benzinga.com/news/legal/25/05/45226604/president-trump-wants-to-reopen-alcatraz-heres-what-it-would-take?utm_source=articleShare">President Trump Wants To Reopen Alcatraz: Here&#8217;s What It Would Take</a>
&#8220;We continue to make great progress with our DCBBS (Data Center Building Block Solution), DLC (Direct Liquid Cooled-2) and AI technology leadership, but some customers delayed making platform decisions in the quarter,&#8221; said Charles Liang, CEO of Supermicro. 
&#8220;We do expect many of those commitments to land in the June and September quarters, reinforcing my confidence in our ability to meet our long-term targets, however, economic uncertainty and tariff impacts may have a short-term impact. We believe that we are well-positioned in the long term to capitalize on the growing market opportunity,&#8221; Liang added.
Outlook:&nbsp;Super Micro expects net sales of $5.6 billion to $6.4 billion for the fourth quarter and non-GAAP net income of 40 cents to 50 cents per diluted share.
SMCI Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Super Micro Computer stock was down 4.07% after-hours at $31.60 on Tuesday.  
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45228179/upwork-delivers-solid-start-to-2025-analyst?utm_source=articleShare">Upwork Delivers &#8216;Solid Start To 2025&#8217;: Analyst&nbsp;</a></li>
</ul>
Photo: Shutterstock

After-Hours Center

Movers

Super Micro Computer Stock Slips After Q3 Results: 'Uncertainty And Tariffs May Have A Short-Term Impact,' CEO Says

Eastern Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EML#NASDAQ">EML</a>) reported quarterly earnings of $0.32 per share which missed the analyst consensus estimate of $0.41 by 21.95 percent. This is a 3.23 percent increase over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $63.30 million which missed the analyst consensus estimate of $71.33 million by 11.26 percent. This is a 6.81 percent decrease over sales of $67.93 million the same period last year.

Eastern Co Q1 Adj. EPS $0.32 Misses $0.41 Estimate, Sales $63.30M Miss $71.33M Estimate

Press Releases

GATX Corporation Announces Quarterly Dividend

GATX Corporation Receives Responsible Care® Excellence in Partnership Award

GATX Corporation Sets Date for 2024 Fourth-Quarter Earnings Release and Conference Call

GATX Corporation Reports 2024 Fourth-Quarter and Full-Year Results

GATX Corporation Announces Quarterly Dividend Increase

GATX Corporation to Present at the Stifel 2025 Transportation & Logistics Conference

GATX Corporation at the Stifel 2025 Transportation & Logistics Conference Cancelled

GATX Corporation Sets Date for 2025 First-Quarter Earnings Release and Conference Call

Comments

GATX

뉴스

파트너 / 기고자

벤징가 글로벌